Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783126783> ?p ?o ?g. }
- W2783126783 endingPage "41" @default.
- W2783126783 startingPage "22" @default.
- W2783126783 abstract "The voltage-gated Na+ channel subtype Nav1.7 is important for pain and itch in rodents and humans. We previously showed that a Nav1.7-targeting monoclonal antibody (SVmab) reduces Na+ currents and pain and itch responses in mice. Here, we investigated whether recombinant SVmab (rSVmab) binds to and blocks Nav1.7 similar to SVmab. ELISA tests revealed that SVmab was capable of binding to Nav1.7-expressing HEK293 cells, mouse DRG neurons, human nerve tissue, and the voltage-sensor domain II of Nav1.7. In contrast, rSVmab showed no or weak binding to Nav1.7 in these tests. Patch-clamp recordings showed that SVmab, but not rSVmab, markedly inhibited Na+ currents in Nav1.7-expressing HEK293 cells. Notably, electrical field stimulation increased the blocking activity of SVmab and rSVmab in Nav1.7-expressing HEK293 cells. SVmab was more effective than rSVmab in inhibiting paclitaxel-induced mechanical allodynia. SVmab also bound to human DRG neurons and inhibited their Na+ currents. Finally, potential reasons for the differential efficacy of SVmab and rSVmab and future directions are discussed." @default.
- W2783126783 created "2018-01-26" @default.
- W2783126783 creator A5014506158 @default.
- W2783126783 creator A5017163037 @default.
- W2783126783 creator A5019906052 @default.
- W2783126783 creator A5020073812 @default.
- W2783126783 creator A5022255280 @default.
- W2783126783 creator A5022998842 @default.
- W2783126783 creator A5024761554 @default.
- W2783126783 creator A5031189107 @default.
- W2783126783 creator A5057668541 @default.
- W2783126783 creator A5057756650 @default.
- W2783126783 creator A5064138185 @default.
- W2783126783 creator A5066306778 @default.
- W2783126783 creator A5079347887 @default.
- W2783126783 creator A5082633022 @default.
- W2783126783 creator A5090381112 @default.
- W2783126783 date "2018-01-15" @default.
- W2783126783 modified "2023-09-27" @default.
- W2783126783 title "Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7" @default.
- W2783126783 cites W1574909190 @default.
- W2783126783 cites W1580632486 @default.
- W2783126783 cites W1965522673 @default.
- W2783126783 cites W1966815375 @default.
- W2783126783 cites W1968037422 @default.
- W2783126783 cites W1969055178 @default.
- W2783126783 cites W1976681671 @default.
- W2783126783 cites W1979626824 @default.
- W2783126783 cites W1981232430 @default.
- W2783126783 cites W1993424762 @default.
- W2783126783 cites W1998634781 @default.
- W2783126783 cites W2000144429 @default.
- W2783126783 cites W2000784356 @default.
- W2783126783 cites W2004998378 @default.
- W2783126783 cites W2008572521 @default.
- W2783126783 cites W2022756362 @default.
- W2783126783 cites W2025949383 @default.
- W2783126783 cites W2026551512 @default.
- W2783126783 cites W2032734987 @default.
- W2783126783 cites W2038050499 @default.
- W2783126783 cites W2046486142 @default.
- W2783126783 cites W2049433094 @default.
- W2783126783 cites W2053242178 @default.
- W2783126783 cites W2054171053 @default.
- W2783126783 cites W2076923772 @default.
- W2783126783 cites W2082983474 @default.
- W2783126783 cites W2087039796 @default.
- W2783126783 cites W2094677101 @default.
- W2783126783 cites W2097979065 @default.
- W2783126783 cites W2104415321 @default.
- W2783126783 cites W2106670341 @default.
- W2783126783 cites W2108114952 @default.
- W2783126783 cites W2108438677 @default.
- W2783126783 cites W2108652707 @default.
- W2783126783 cites W2110251626 @default.
- W2783126783 cites W2114425179 @default.
- W2783126783 cites W2125056253 @default.
- W2783126783 cites W2126246278 @default.
- W2783126783 cites W2129706672 @default.
- W2783126783 cites W2130972481 @default.
- W2783126783 cites W2132856129 @default.
- W2783126783 cites W2142953265 @default.
- W2783126783 cites W2147466595 @default.
- W2783126783 cites W2152963050 @default.
- W2783126783 cites W2163151214 @default.
- W2783126783 cites W2185789127 @default.
- W2783126783 cites W2195259275 @default.
- W2783126783 cites W2239052723 @default.
- W2783126783 cites W2250059298 @default.
- W2783126783 cites W2276561927 @default.
- W2783126783 cites W2314467531 @default.
- W2783126783 cites W2461092175 @default.
- W2783126783 cites W2510317279 @default.
- W2783126783 cites W2549842750 @default.
- W2783126783 cites W2557814822 @default.
- W2783126783 cites W2583133006 @default.
- W2783126783 cites W2606254225 @default.
- W2783126783 cites W2618571774 @default.
- W2783126783 cites W4210308225 @default.
- W2783126783 doi "https://doi.org/10.1007/s12264-018-0203-0" @default.
- W2783126783 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5799132" @default.
- W2783126783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29333591" @default.
- W2783126783 hasPublicationYear "2018" @default.
- W2783126783 type Work @default.
- W2783126783 sameAs 2783126783 @default.
- W2783126783 citedByCount "22" @default.
- W2783126783 countsByYear W27831267832018 @default.
- W2783126783 countsByYear W27831267832019 @default.
- W2783126783 countsByYear W27831267832020 @default.
- W2783126783 countsByYear W27831267832021 @default.
- W2783126783 countsByYear W27831267832022 @default.
- W2783126783 crossrefType "journal-article" @default.
- W2783126783 hasAuthorship W2783126783A5014506158 @default.
- W2783126783 hasAuthorship W2783126783A5017163037 @default.
- W2783126783 hasAuthorship W2783126783A5019906052 @default.
- W2783126783 hasAuthorship W2783126783A5020073812 @default.
- W2783126783 hasAuthorship W2783126783A5022255280 @default.
- W2783126783 hasAuthorship W2783126783A5022998842 @default.